Population
Patients with stroke
Design
Cohort
Authors
Loading...
May reflect modern preventive therapies; leaves open need for larger samples in future secondary prevention trials.
Modern preventive medications may have lowered recurrent stroke rates, suggesting future secondary prevention trials will require larger sample sizes.
Callaly et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: